myriad genetics inc (MYGN:NASDAQ GS)
Executive Profile*
John T. Henderson BSc. MB ChB MRCP, M.D.Chairman, Chairman of Strategic Committee, Member of Nominating & Governance Committee and Member of Compensation Committee, Myriad Genetics Inc. |
| Age | Total Calculated Compensation | This person is connected to 43 board members in 3 different organizations across 5 different industries. See Board Relationships |
| 67 | $416,241 |
Background*
Dr. John T. Henderson, M.D. serves as the President of FuturePharm LLC. Dr. Henderson has been a Consultant to the Pharmaceutical industry through Futurepharm LLC since December 2000. Dr. Henderson has extensive experience in a broad range of therapeutic areas, including cardiovascular, the central nervous system, anti-infective, anti-inflammatory agents, urology and gastro-enterology. Prior to FuturePharm LLC, from December 1974 to December 2000, he served at Pfizer ...
Corporate Headquarters*320 Wakara WaySalt Lake City, Utah 84108 United States Phone: 801-584-3600 Fax: 801-584-3640 Board Members Memberships*Chairman 2002-N/A Former Lead Director, Member of Audit Committee and Member of Corporate Governance and Nominating Committee 2004-Present Chairman, Chairman of Strategic Committee, Member of Nominating & Governance Committee and Member of Compensation Committee 2004-N/A Former Director 2009-Present Director, Member of Audit Committee and Member of Nominating & Governance Committee 2009-2013 Former Director, Chairman of Nominating & Governance Committee and Member of Audit Committee
Education*Unknown/Other Education 1968 University of Edinburgh in Scotland BS 1965 University of Edinburgh in Scotland MD University of Edinburgh in Scotland
Other Affiliations* |
Annual Compensation*There is no Annual Compensation data available.Stock Options*
Total Compensation*
|
| Recently Viewed | |||
| MYGN:US | $31.48 USD | -0.71 |  |
COMPETITOR COMPENSATION
| Name | Position/ Company | Compensation |
| Marc D. Grodman M.D. | Founder, Chairman, Chief Executive Officer, President and Managing Director Bio-Reference Laboratories Inc. | $1.2M |
| Elazar Rabbani Ph.D. | Co-Founder, Chairman, Chief Executive Officer and Secretary Enzo Biochem Inc. | $555.5K |
| Douglas M. VanOort | Executive Chairman and Chief Executive Officer Neogenomics Inc. | $613.0K |
| Susan Searle | Chief Executive Officer, Executive Director and Member of Investment Committee Imperial Innovations Group plc | 245.0K GBP |
| Kimberly J. Popovits | Chairman, Chief Executive Officer, President and Member of Non-Management Stock Option Committee Genomic Health Inc. | $600.0K | Compensation as of Fiscal Year 2012. |
Post a JobJobs
- Salt Lake City, UT | Myriad GeneticsPosted: May 23
- Salt Lake City, UT | Myriad GeneticsPosted: May 23
- Salt Lake City, UT | Myriad GeneticsPosted: May 23
- Salt Lake City, UT | Myriad GeneticsPosted: May 23
Sponsored Financial Commentaries
Sponsored Links
To contact MYRIAD GENETICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.
Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.
